tipifarnib has been researched along with Ache in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouche, O; Bugat, R; De Porre, P; Eckhardt, SG; Maurel, J; Michiels, B; Smith, D; Steward, WP; van de Velde, H | 1 |
| Bouffet, E; Drake, JM; Parkin, P; Rutka, JT; Serletis, D; Shroff, M | 1 |
1 trial(s) available for tipifarnib and Ache
| Article | Year |
|---|---|
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Deoxycytidine; Double-Blind Method; Europe; Female; Gemcitabine; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Pain; Pain Measurement; Pancreatic Neoplasms; Patient Satisfaction; Placebo Effect; Quinolones; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; United States | 2009 |
1 other study(ies) available for tipifarnib and Ache
| Article | Year |
|---|---|
Massive plexiform neurofibromas in childhood: natural history and management issues.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cyclophosphamide; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Neurofibroma, Plexiform; Neurosurgical Procedures; Pain; Quinolones; Respiration Disorders; Retrospective Studies | 2007 |